MEDIROM Healthcare Technologies Inc ADR (NASDAQ: MRM) has seen a decline in its stock price by -1.59 in relation to its previous close of 0.63. However, the company has experienced a -8.82% decline in its stock price over the last five trading sessions. globenewswire.com reported 2025-03-13 that TOKYO, March 13, 2025 (GLOBE NEWSWIRE) — MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) (the “Company” or “MEDIROM”) announces that Yasuhiro Hayami, Chief Business Officer of MEDIROM Mother Labs Inc. (“Mother Labs”), a subsidiary of the Company, has made a second investment in Mother Labs’ Series A financing at a pre-money valuation of JPY9 billion (as of March 13, 2025, approximately US$60 million). This new investment follows Mr. Hayami’s initial investment in the Series A financing in December 2024. Mr. Hayami is a committed senior executive of Mother Labs and shares MEDIROM’s corporate philosophy and vision as well as commitment to future growth potential.
Is It Worth Investing in MEDIROM Healthcare Technologies Inc ADR (NASDAQ: MRM) Right Now?
Company’s 36-month beta value is 0.41.Analysts have differing opinions on the stock, with 1 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The average trading volume of MRM on March 14, 2025 was 82.97K shares.
MRM’s Market Performance
MRM’s stock has seen a -8.82% decrease for the week, with a -31.52% drop in the past month and a -77.86% fall in the past quarter. The volatility ratio for the week is 11.41%, and the volatility levels for the past 30 days are at 10.37% for MEDIROM Healthcare Technologies Inc ADR The simple moving average for the past 20 days is -15.39% for MRM’s stock, with a -77.90% simple moving average for the past 200 days.
MRM Trading at -29.17% from the 50-Day Moving Average
After a stumble in the market that brought MRM to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -92.61% of loss for the given period.
Volatility was left at 10.37%, however, over the last 30 days, the volatility rate increased by 11.41%, as shares sank -29.54% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -40.95% lower at present.
During the last 5 trading sessions, MRM fell by -8.82%, which changed the moving average for the period of 200-days by -88.76% in comparison to the 20-day moving average, which settled at $0.7328. In addition, MEDIROM Healthcare Technologies Inc ADR saw -39.81% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for MRM
Current profitability levels for the company are sitting at:
- -0.02 for the present operating margin
- 0.25 for the gross margin
The net margin for MEDIROM Healthcare Technologies Inc ADR stands at 0.13. The total capital return value is set at -0.02. Equity return is now at value 112.23, with -1.55 for asset returns.
Based on MEDIROM Healthcare Technologies Inc ADR (MRM), the company’s capital structure generated 0.95 points at debt to capital in total, while cash flow to debt ratio is standing at -0.22.
Currently, EBITDA for the company is 310.08 million with net debt to EBITDA at 50.3. When we switch over and look at the enterprise to sales, we see a ratio of 1.11. The receivables turnover for the company is 5.77for trailing twelve months and the total asset turnover is 0.52. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.34.
Conclusion
In a nutshell, MEDIROM Healthcare Technologies Inc ADR (MRM) has experienced a bad performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
